Track the 차백신연구소 stock price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 차백신연구소 has logged 30 insider filings. Market capitalisation: €60.7bn. The latest transaction was reported on 11 May 2026 (Sale). Among the most active insiders: 고정재. Every trade is free.
30
Insider Decl.
n/a
Thresholds
€39m
7 ops.
Buy Volume
€23m
8 ops.
Sell Volume
22Σ signal
Buys €39m€23m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 23,637 of 29,063 companies
29.8
score / 100
Value
10
Quality
49
FCF yld-17%
Earn yld-24%
EV/EBITDA·
ROE-89%
Gross mgn91%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.